Skanda Lifesciences Private Limited

Skanda Lifesciences Private Limited - business outsourcing in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U73100KA2012PTC066675 Incorporated 13 November 2012 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company business outsourcing MSME · Small
Data last updated
Revenue · FY 2025
₹4.02 Cr
▲ 16% YoY
Net profit · FY 2025
₹36.3 Lakh
Net margin 9%
EBITDA · FY 2025
₹91.18 Lakh
EBITDA margin 22.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1.29 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
28
Provident fund records

About Skanda Lifesciences Private Limited

Data last updated:

Skanda Lifesciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the accounting and financial analysis segment of the business process outsourcing sector. It was incorporated on 13 November 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2012PTC066675. Its GSTIN is 29AASCS3496B1ZU (Karnataka).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Swathi Shetty and Shivnna Yogisha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.02 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹36.3 Lakh (net margin 9%) and EBITDA of ₹91.18 Lakh (EBITDA margin 22.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 19% over five years.

The company has about 28 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Skanda Life Sciences. As per MCA filings, the company has open charges of ₹1.29 Cr on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹20 Lakh; the latest was in February 2013.

Skanda Lifesciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0083183). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website skandalifesciences.com.

Company details

CIN U73100KA2012PTC066675
Registration Number 066675
Incorporation Date 13 November 2012
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0083183

Recognitions & Rankings of Skanda Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-KR-03-0083183

Contact details

Skanda Lifesciences Private Limited's registered office is in Bangalore, Karnataka. Its website is skandalifesciences.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Sy No. 47 No.10 11 & 12 Shree Shyla Bramara Chandana Layout Srigandhada Kaval Naga, Rbhavi, Bangalore, Karnataka, India – 560091
  • Industry
    Business Outsourcing, Accounting and Financial Analysis

To see the full contact details of Skanda Lifesciences Private Limited, buy the company report.

Comprehensive company report
Skanda Lifesciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Skanda Lifesciences operates one associated brand: Skanda Life Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
Company offering drug discovery and preclinical development servicesskandalifesciences.com

Business activity

The main business activity of Skanda Lifesciences is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Skanda Lifesciences Private Limited, buy the company report.

Financials of Skanda Lifesciences Private Limited

FY 2025 filings available

Skanda Lifesciences Private Limited reported revenue of ₹4.02 Cr (up 16% YoY) for FY 2025.

Revenue · FY 2025
₹4.02 Cr ▲ 16%
Net profit · FY 2025
₹36.3 Lakh margin 9%
EBITDA · FY 2025
₹91.18 Lakh margin 22.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 8%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 13%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 16% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹91.18 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹36.3 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin22.7%
Net Profit Margin9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Skanda Lifesciences Private Limited, buy the company report.

Board of directors of Skanda Lifesciences Private Limited

Skanda Lifesciences has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Swathi ShettyDirector13 Nov 201213 Years 11 MonthsCurrent
Shivnna YogishaDirector13 Nov 201213 Years 11 MonthsCurrent

Auditor

Skanda Lifesciences Private Limited is audited by NAVEENKUMAR D V & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
NAVEENKUMAR D V & ASSOCIATESFY 2019017542S

Shareholding

The shareholding of Skanda Lifesciences Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Skanda Lifesciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.29 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹0.87 Cr
Others₹0.27 Cr
Bank of Baroda₹0.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Mar 2023100691426State Bank of India₹26.5 LakhOpen
31 Jan 2020100325967State Bank of India₹60 LakhOpen
12 Dec 2018100225081Others₹27 LakhOpen
05 Apr 201310423998Bank of Baroda₹15 LakhOpen

Total charge records: 4 View all charges

Deals & funding

Skanda Lifesciences Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹20 Lakh; the latest was in February 2013.

Total deals
1
Funding round
1
Disclosed funding
₹20 Lakh

Deals on record (1 of 1)

WhenDealAmountParties
Feb 2013Funding round₹20 LakhInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Skanda Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Skanda Lifesciences Private Limited has a workforce of 28 employees on its EPFO records as of Mar 21, 2024, across 1 active EPFO establishment.

Employee count
28
Active EPFO establishments
1
Employee growth
16.67%

GST

Skanda Lifesciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AASCS3496B1ZUKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Skanda Lifesciences Private Limited, buy the company report.

Recent activity

Skanda Lifesciences Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Shivnna Yogisha was appointed as Director on 13 Nov 2012.

AGM
Skanda Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Skanda Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with State Bank Of India amounted to Rs. 26.50 Lakh with Charge ID 100691426 was registered on 07 Mar 2023.
Charges
A charge with State Bank Of India amounted to Rs. 60.00 Lakh with Charge ID 100325967 was registered on 31 Jan 2020.
Charges
A charge with Others amounted to Rs. 27.00 Lakh with Charge ID 100225081 was registered on 12 Dec 2018.
Charges
A charge with Bank Of Baroda amounted to Rs. 15.00 Lakh with Charge ID 10423998 was registered on 05 Apr 2013.
Appointed
Shivnna Yogisha was appointed as Director.
Appointed
Swathi Shetty was appointed as Director.
Incorporation
13 Nov 2012
Skanda Lifesciences Private Limited was registered on 13 Nov 2012 with Roc Bangalore & aged 13 years 11 months as per MCA records.

Frequently asked questions

Skanda Lifesciences is an active private limited company based in Bangalore, Karnataka, India. The company works in accounting and financial analysis, within the business outsourcing industry. It was incorporated on 13 November 2012 (14+ years old) and is registered under CIN U73100KA2012PTC066675.

Skanda Lifesciences has 2 current directors:

The latest financial statements of Skanda Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Skanda Lifesciences is 29AASCS3496B1ZU, registered in Karnataka.

The CIN (Corporate Identification Number) of Skanda Lifesciences is U73100KA2012PTC066675. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Skanda Lifesciences was incorporated on 13 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.

Skanda Lifesciences has 1 deal on record (1 funding round), with disclosed funding of ₹20 Lakh; the latest was in February 2013.

Shivnna Yogisha was appointed as Director on 13 Nov 2012. Swathi Shetty was appointed as Director on 13 Nov 2012.

Yes, Skanda Lifesciences is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0083183).

Skanda Lifesciences can be reached through the website skandalifesciences.com. Its registered office is in Bangalore, Karnataka, India.